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The management of a group of epilepsy patients from primary care, in a geographical area with clear epilepsy management
guidelines and secondary care clinics is surveyed. Suggestions are made to improve liaison between primary and secondary care
as well as epilepsy management in primary care.
All 42 local primary care practices were invited to take part in this project. A study day providing a broad overview of epilepsy
management was held. Those attending were expected to identify all patients in their practice with epilepsy using diagnostic
codes and prescribing data.
Nine of the invited 42 practices took part in the project, and identified 506 patients prescribed anti-epilepsy drugs (AEDs).
Three hundred and three patients were invited for review by their practice nurse, following exclusion of those prescribed AEDs
for other conditions, children and those already under specialist review. One hundred and sixteen patients attended for review.
Seventy-one patients were identified as requiring specialist review and a consultant neurologist, epilepsy nurse specialist and
clinical assistant completed them. Of the 71 patients 31 had experienced no seizures for 5 years, 40 had experienced seizures in
the past 5 years, of whom 32 had experienced seizures in the last year. Sixteen were suffering at least one seizure per month,
and a few had poorly controlled epilepsy.
Patients were taking mainly Phenytoin, Carbamazepine and Sodium valproate. Twenty were taking polytherapy and one no
treatment.
Fifty-two patients reported side effects and 15 poor compliance.
Many patients reviewed were considered to be taking unnecessary medication and suffering unnecessary side effects.
There is a need for improved epilepsy management in primary care and better liaison between primary and secondary care.
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INTRODUCTION
Epilepsy is the most common serious neurological
condition1. The report of the working group on Ser-
vices for people with epilepsy2 recommends that
following initial diagnosis and treatment by a neu-
rologist, epilepsy is a condition best managed in
the primary care setting in the majority of cases.
However, ‘epilepsy remains under treated despite
advances in the development of effective drug treat-
ments, and many patients still receive inadequate
or inappropriate therapy’3. Patients with epilepsy in
primary care are treated if they attend their prac-
tice but are commonly not followed up if they fail
to attend3, 12. Chappell and Smithson4 found only
9% of patients had an organised regular review of
their epilepsy and Moran et al.5 found that many
patients with severe epilepsy had received no pri-
mary care consultations in the previous year. Many
patients with severe epilepsy did not receive any
specialist input into their care and few patients with
controlled epilepsy received regular medical super-
vision although they were taking anti-epilepsy drugs
(AEDs).
Several government reports2, 6 have suggested
ways to improve epilepsy care including establishing
epilepsy clinics in district general hospitals as well as
the use of local guidelines aimed at improving overall
care.
The aim of this study was to survey the care of
epilepsy patients managed in the primary care setting
in a geographical area where there is a well established
epilepsy clinic with local guidelines for referral of
patients for diagnosis and treatment.
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METHOD
An ‘Audit of epilepsy services in Northamptonshire’7
was completed in response to the NHS executive let-
ter EL (95)1208 which was aimed at co-ordinating
a number of initiatives to improve epilepsy ser-
vices. This audit highlighted problems locally includ-
ing poor review of patients in primary care, and a
lack of communication and counselling available to
patients.
The neurology team responded to this report by
inviting local practices to participate in an epilepsy
project. It commenced with a study day giving a broad
overview of epilepsy management, targeted at practice
nurses who it was anticipated would be most likely
to complete the necessary audit. Interested GPs were
also welcomed. Those practice nurses and GPs who
attended were asked to commit to completing an audit
to identify all patients in their practice with epilepsy,
by database searches using diagnostic codes and pre-
scribing data.
Identified patients were then offered an appointment
for review by their practice nurse or GP. Patients were
excluded if they were less than 16 years of age, as they
would be under paediatric review. Patients already un-
der specialist review were also excluded as the study
was concentrating on reviewing management in the
primary care setting.
At the practice review a patient assessment form
was completed. This gathered information including
patient details, description of attacks, frequency and
date of last attack, medication and dosage, compliance,
side effects, driving, employment, contraception and
pregnancy. This form had trigger points to highlight
patients who might benefit from a specialist review,
e.g. patients prescribed the older AEDs or Vigabatrim
(due to potential visual field defects), those whose
compliance was poor or who suffered moderate to
severe side effects, patients suffering regular seizures,
planning pregnancy, or the patient simply requested
the opportunity for specialist review.
Patient assessment forms were completed by the
practice nurse or GP and forwarded to the epilepsy
specialist nurse who allocated patients to six evening
clinics, held monthly over a period of 6 months. The
patients were reviewed by the consultant neurologist,
clinical assistant or specialist nurse.
Recommendations for treatment change were made
as appropriate following discussion with the pa-
tient. The GP and practice nurse were informed by
letter with advice about implementing the recom-
mended changes. The opportunity was also taken to
discuss life style issues surrounding diagnosis and
seizure type, contraception, pregnancy, driving and
employment. An EEG technician was available dur-
ing the clinics to carry out an EEG as necessary, and
funding was available for scans if it was felt to be
appropriate.
RESULTS
Of 42 local practices invited to take part in the project
12 practices attended the initial study day and 9 prac-
tices went ahead and surveyed their epilepsy popu-
lations. These 9 practices, with a patient population
of 70 074 (23% of the county population), identified
506 patients prescribed AEDs (11.2% of the estimated
4500 patients with active epilepsy in the county).
After exclusion criteria were applied the remaining
303 patients (59%) were offered appointments for re-
view by their practice nurse, of whom 116 patients
(38%) attended. Of these 116 patients 76 patients
(65%) were referred for specialist review and 71 pa-
tients (93%) attended.
Thirty-five male and 36 female patients were re-
viewed. Their ages ranged between 19 and 92 years
with a mean age of 46. The most common seizure
types reported were complex partial seizures and
tonic/clonic seizures of a primary or secondary gen-
eralised nature. Date of diagnosis occurred between
1924 and 1999. Diagnosis was uncertain in 3 pa-
tients, 5 patients had learning disabilities, 1 patient
had psychiatric problems and 2 patients had physical
problems associated with a diagnosis of meningitis in
one case and brain injury in the other. Eight patients
had EEG recordings and 2 had CT scans following
their review.
Thirty-one patients (43%) were seizure free (no
seizures for 5 years). Thirty-two patients (45%) had
suffered seizures in the previous year with 16 (22.5%)
of these still suffering at least one seizure per month,
with 5 patients suffering very frequent seizures
(graph 1).
Most of the patients reviewed reported side ef-
fect problems including 29 patients (40%) reporting
drowsiness, 20 patients (28%) reporting difficul-
ties with concentration, 14 patients (19%) reporting
aggression or agitation and 14 patients (19%) com-
plaining of headache. On closer questioning it wasn’t
felt that all the side effect complaints were related to
AEDs however.
Fifteen patients (21%) reported poor compliance
and 10 patients (14%) had their medication regime
adjusted to either a once or twice daily prescrip-
tion instead of three or four times daily to improve
compliance.
Ten patients (14%) had the dosage of their medica-
tion increased to improve fit control, 26 patients (36%)
had medications stopped, 8 patients (11%) had new
drugs commenced and 12 patients (16%) refused drug
alterations (Tables 1 and 2).
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Table 1: Number of patients taking each epilepsy
medication before and after review.
Before review After review
Phenytoin 28 16
Phenobarbitone 5 2
Primidone 5 3
Carbamazepine 30 24
Sodium valproate 26 26
Clobazam 2 1
Diazepam 1 1
Lamotrigine 2 7
Ethosuximide 1 1
Table 2: Comparison of patients prescribed no treatment,
monotherapy and polytherapy, before and after review.
Before review After review
No medication 1 10
Monotherapy 50 47
Polytherapy 20 14
DISCUSSION
This study was only able to focus on a small num-
ber of self-chosen local primary care practices within
Northamptonshire. It could therefore be argued that
those practices that opted into the study did so be-
cause they were aware that their delivery of epilepsy
care was inadequate and they wanted to improve pro-
vision of epilepsy management within primary care.
In contrast the practices that chose not to be included
in the study may have perceived that their provision of
epilepsy management within the primary care setting
adhered to good levels of practice.
Inclusion into this study was further compounded by
the factors affecting patient inclusion. Patients already
receiving specialist review were excluded. This group
is likely to include those with severe chronic epilepsy,
as well as a greater number of patients on monother-
apy and therefore fewer side effects as well as greater
satisfaction with care14. Patient inclusion was depen-
dent on the patient having a diagnosis of epilepsy and
receiving prescription AEDs. Clearly the majority of
patients who responded and attended the clinical re-
views had either active epilepsy or inactive epilepsy
that was controlled by medication. The chances of
recruiting patients who were experiencing the most
difficulties as a result of epilepsy and its treatment
were therefore increased, although it would have been
hoped that with clear local guidelines for epilepsy
management and referral, these patients would have
been under specialist review already. These com-
pounding effects within the survey of specific pri-
mary care practices who felt they were not managing
epilepsy care effectively, and a client group of people
with active epilepsy, may in itself have created an
inherently biased study that cannot be used for com-
parative research in primary care studies. It may, how-
ever, be construed that this survey is representative of
the standard of epilepsy management in primary care
throughout the country and further primary care stud-
ies of this type are needed to reinforce or dispute this
viewpoint.
Of the study population 38% of the patients in the
local primary care setting were continuing to take the
older AEDs, (Phenytoin, Phenobarbitone and Primi-
done) when they may no longer have been required
or when a newer AED might have been more suit-
able. These figures are comparable to other recent
studies9, 10. The survey also suggests that with a little
attention to detail it would have been possible to make
slight adjustments to medication regimes and dosage
of AEDs which could have lessened drug side effects
and improved compliance and seizure control.
Chappell4, Jacoby9, and Freeman11 have all found
that GP confidence affects their willingness to become
involved in epilepsy drug management and indicates
the need for ongoing education and support to primary
care practices. Furthermore, it was found that those
patients who refused changes to their treatment regime
feared the risk of break through seizures and the po-
tential loss of their driving licence. This highlights the
importance of initiating treatment with an appropriate
AED at diagnosis as patients are unlikely to consider
a change of medication once they are seizure free and
have regained their driving license.
Evidence from the survey identified that 22.5% of
the study population who were not receiving regu-
lar expert supervision were experiencing at least one
seizure per month with several patients experiencing
hundreds of seizures annually5.
The specialist review offered to patients was in-
tended to be a one off review, with recommendation
for change to be completed in the primary care setting
so as not to strain the already stretched secondary care
epilepsy services. It was felt however that a number of
patients reviewed needed to come under the umbrella
of secondary care due to poor fit control and side ef-
fects, and the need for complex medication changes, as
well as the patients ongoing need for support to com-
plete the recommended changes. It is therefore diffi-
cult to ascertain exactly how many patients completed
all the recommended changes, and for those who did,
to know how much better they were afterwards. We
hope to address this with further research.
CONCLUSIONS
A well organised, local, secondary care epilepsy
service with clear guidelines for referral and manage-
ment of patients with epilepsy is still not sufficient
to ensure patients in the local primary care setting
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will receive optimal management of their epilepsy.
Education packages developed locally for general
practitioners and practice nurses are needed to pro-
vide them with sufficient knowledge and confidence
to make changes in drug regime or dosage to gain
improved fit control, side effects and compliance.
Indeed patients often express the desire for their
epilepsy care to be managed essentially in the primary
care setting12, 13, although Chappell and Smithson4
found that patients preferred the ‘shared’ care option.
Jacoby et al.9 found that GP confidence did affect
their willingness to become involved in epilepsy
treatment and have argued that improved care for
epilepsy is dependent on increasing GP knowledge
and confidence of the condition. An alternative op-
tion would be improving knowledge and confidence
of practice nurses who are already accomplished
at the management of chronic conditions including
asthma and diabetes. With the support of a local
epilepsy specialist nurse it may be possible for ‘shared
care’ between primary and secondary care to be
achieved3, 14.
Patients involved in this project, whether reviewed
at their practice or the specialist review clinic, ex-
pressed delight that someone was taking an interest in
their epilepsy, even if they chose to make no changes
to their treatment. Further research is required to es-
tablish why people with poorly controlled epilepsy,
or perceived side effects are not accessing primary
care, or pressing for improvements in their epilepsy
management.
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